US2005026496 PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS

1. (WO2006014958) PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS

↓

Latest bibliographic data on file with the International Bureau

Pub. No.:		WO/2006/014958		International Application No.:		PCT/US2005/026496
Publication Date:		09.02.2006		International Filing Date:		26.07.2005

IPC:

A61K 35/14 (2006.01), C12Q 1/56 (2006.01), G01N 33/53 (2006.01), G01N 33/86 (2006.01)

Applicants:

BAYER HEALTHCARE LLC [US/US]; 511 Benedict Avenue, Tarrytown, NY 10591-5097 (US) (For All Designated States Except US).
CHAPMAN-MONTGOMERY, Sabrinah, E. [US/US]; (US) (For US Only).
OKRONGLY, David [US/US]; (US) (For US Only).
AHNADI, Charaf, E. [--/CA]; (CA) (For US Only).
WU, Alan [US/US]; (For US Only).
GERVAIS, Andre [--/CA]; (CA) (For US Only)

Inventors:

CHAPMAN-MONTGOMERY, Sabrinah, E.; (US).
OKRONGLY, David; (US).
AHNADI, Charaf, E.; (CA).
WU, Alan; .
GERVAIS, Andre; (CA)

Agent:

ELDERKIN, Dianne, B.; Woodcock Washburn LLP, 2929 Arch Street - Suite 1200, Philadelphia, PA 19104-2891 (US)

Priority Data:

60/591,025		26.07.2004		US
60/603,594		23.08.2004		US

Title

(EN) PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS
(FR) MARQUEURS D'ACTIVATION DE PLAQUETTES UTILISES COMME PREDICTEURS DE MALADIE ET DE REPONSE A UN TRAITEMENT ET PERMETTANT DE SURVEILLER UNE EVOLUTION THERAPEUTIQUE

Abstract:

(EN)Methods for assessing patient risk for platelet-affected disease states are disclosed. Also disclosed are methods for predicting the appropriateness of platelet antagonist therapy, and for monitoring patients during therapeutic intervention or during a combined regimen of therapy and angioplasty.
(FR)L'invention concerne des procédés permettant d'évaluer le risque pour un patient d'être atteint d'états pathologiques affectant les plaquettes. L'invention concerne également des procédés permettant de prévoir la pertinence d'un traitement antagoniste des plaquettes et de surveiller des patients pendant l'intervention thérapeutique ou pendant un régime combiné de traitement et d'angioplastie.

Designated States:

AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).

Publication Language:	English (EN)
Filing Language:	English (EN)

Default Search Form
Default Tab Search Form
Interface Language
Skins
Multiple Windows Interface
Tooltip Help
IPC Tooltip Help